Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sedation × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 16 Breast Neoplasms 10 Carcinoma, Non-Small-Cell Lung 9 Prostatic Neoplasms 5 Melanoma 5 Lung Neoplasms 5 Solid Tumor 3 Neoplasm Metastasis 3 Lymphoma, Non-Hodgkin 3 Leukemia, Myeloid, Acute 3 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pain 2 Lymphoma 2 Glioma 2 Gastrointestinal Stromal Tumors 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Choledochal Cyst 2 Carcinoma 2 Anxiety Disorders 2 Advanced Solid Tumor 2 Advanced Malignancies 2 cMET-dysregulated Advanced Solid Tumors 1 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Terminal Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumours 1

Interventions

Propofol 1 Midazolam 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03343873 2024-08-01

ACTION

Beijing Tiantan Hospital

Phase NA Recruiting

Sedation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡